Revue: | Biocell |
Base de datos: | PERIÓDICA |
Número de sistema: | 000330405 |
ISSN: | 0327-9545 |
Autores: | Vorster, Chris1 Joubert, Annie1 |
Instituciones: | 1University of Pretoria, Department of Physiology, Pretoria, Transvaal. Sudáfrica |
Año: | 2010 |
Periodo: | Ago |
Volumen: | 34 |
Número: | 2 |
Paginación: | 71-79 |
País: | Argentina |
Idioma: | Inglés |
Tipo de documento: | Artículo |
Enfoque: | Experimental, aplicado |
Resumen en inglés | In the search for new and improved anticancer therapies, researchers have identified several potentially useful compounds. One of these agents is 2-methoxyestradiol-bis-sulphamate (2ME-BM), a sulphamoylated derivative of 2-methoxyestradiol. The objective of this study was to evaluate 2ME-BM’s in vitro efficacy as antiproliferative agent in the MCF-7 breast adenocarcinoma cell line. Light- and fluorescent microscopy showed decreased cell density, increased apoptotic characteristics and significant ultrastructural aberrations indicative of autophagic cell death after 24 hours of exposure at a concentration of 0.4μM. In addition, mitotic indices revealed that 2ME-BM induces a G2M block. The latter was confirmed by flow cytometric analyses where increased sub-G1 and G2/M fractions, as well as an increase in cyclin B1 levels were observed. Further in vitro research into the mechanism of this potentially useful anticancer compound is thus warranted |
Disciplinas: | Biología, Medicina |
Palabras clave: | Biología celular, Oncología, Bioensayos, 2-metoxiestradiol-bis-sulfamato, Crecimiento celular, Ciclo celular, Adenocarcinoma, Apoptosis, Autofagia |
Keyword: | Biology, Medicine, Cell biology, Oncology, Bioassays, 2-methoxyestradiol-bis-sulphamate, Cell growth, Cell cycle, Adenocarcinoma, Apoptosis, Autophagy |
Texte intégral: | Texto completo (Ver PDF) |